INSIGHTEC, INC.
DALLAS, TX

INSIGHTEC, INC., incorporated on February 11, 2013 in Dallas, Texas (Filed Number F13000000634), is renowned for pioneering non-invasive medical technologies. The company achieved significant recognition when its Exablate® 2000 became the first FDA-approved MRI-guided focused ultrasound platform to treat essential tremor, earning a prestigious gold award. INSIGHTEC was celebrated on the World Medical Innovation Forum's 'Disruptive Dozen' list for integrating transcranial MRI-guided focused ultrasound with microbubbles technology to precisely target deep bodily tissues without incisions or radiation. The company is listed as one of Technology Pioneers by the World Economic Forum in 2008, having impressed a panel of leading experts from over 273 nominees. Red Herring recognized INSIGHTEC for its innovative approach, naming it on their Red Herring 100 Europe 2007 list alongside future giants like Google and eBay in its early stages. Its Exablate® technology also garnered Frost and Sullivan’s Technical Innovation Award in 2005, marking it as a forefront innovator in non-invasive medical devices. INSIGHTEC continued to be recognized for its technological advancements when it claimed Wall St. Journal's Technology Innovation Award—Bronze Winner—for its Exablate Neuro solution. INSIGHTEC partners with healthcare providers offering state-of-the-art MR-guided focused ultrasound platforms. Beyond providing the Exablate platform, INSIGHTEC delivers comprehensive clinical and commercial support, maintenance services, and marketing guidance to ensure operational success. Dedicated specialists offer personalized clinical training and continuous support until sites are fully certified and operationally autonomous. The company’s commercial development team works closely with partners to align organizational goals, tackle reimbursement challenges, and establish optimal business models for platform deployment. Regular in-person service ensures systems operate safely and efficiently. INSIGHTEC's Chief Commercial Officer, Jun (Jim) Tao, brings extensive experience from Constellium, CITIC Capital Holdings, American Securities LLC, and General Electric Company, contributing to the firm’s strategic commercial success. Headquartered at 4851 LBJ Freeway in Dallas, Texas, with mailing address in Leon County, Florida, INSIGHTEC is recognized under FEI Number 39-1948614. The company's last significant event was a reinstatement on October 10, 2016, and the next annual report due for filing in 2025. Their efforts have marked them as leaders in medical technology innovation.